These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1267 related items for PubMed ID: 29328485

  • 1. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X, Ran L, Liu Y, Zhong SH, Zhou PP, Liao MX, Fang W.
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [Abstract] [Full Text] [Related]

  • 2. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ, Liu HL.
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [Abstract] [Full Text] [Related]

  • 3. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.
    Xia C, Liu C, He Z, Cai Y, Chen J.
    J Exp Clin Cancer Res; 2020 Jul 06; 39(1):127. PubMed ID: 32631421
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition.
    Choi HS, Lee HM, Jang YJ, Kim CH, Ryu CJ.
    Stem Cells; 2013 Dec 06; 31(12):2647-58. PubMed ID: 23495120
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
    Zhu B, Wei Y.
    Cancer Med; 2020 Jan 06; 9(2):783-796. PubMed ID: 31957323
    [Abstract] [Full Text] [Related]

  • 6. β-Asarone Induces Apoptosis and Cell Cycle Arrest of Human Glioma U251 Cells via Suppression of HnRNP A2/B1-Mediated Pathway In Vitro and In Vivo.
    Li L, Yang Y, Wu M, Yu Z, Wang C, Dou G, He H, Wang H, Yang N, Qi H, Xu X.
    Molecules; 2018 May 03; 23(5):. PubMed ID: 29751524
    [Abstract] [Full Text] [Related]

  • 7. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B, Feng Y, Sun Y, Ji D, Qian W, Zhang Z, Wang Q, Zhang Y, Zhang C, Sun Y.
    Oncol Rep; 2018 Oct 03; 40(4):1885-1896. PubMed ID: 30066935
    [Abstract] [Full Text] [Related]

  • 8. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
    Jin X, Zhu L, Cui Z, Tang J, Xie M, Ren G.
    Clin Transl Oncol; 2019 Sep 03; 21(9):1207-1219. PubMed ID: 30767161
    [Abstract] [Full Text] [Related]

  • 9. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB.
    Zhao H, Xu J, Wang Y, Jiang R, Li X, Zhang L, Che Y.
    Surg Oncol; 2018 Sep 03; 27(3):495-502. PubMed ID: 30217308
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 03; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human cervical cancer cell growth by Salviolone is mediated via autophagy induction, cell migration and cell invasion suppression, G2/M cell cycle arrest and downregulation of Nf-kB/m-TOR/PI3K/AKT pathway.
    Zhang Y, Li G, Ji C.
    J BUON; 2018 Jul 03; 23(6):1739-1744. PubMed ID: 30610802
    [Abstract] [Full Text] [Related]

  • 12. Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells.
    Xia C, He Z, Cai Y, Liang S.
    Eur J Pharmacol; 2020 May 15; 875():173057. PubMed ID: 32135122
    [Abstract] [Full Text] [Related]

  • 13. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
    Li X, Song Y, Zhang P, Zhu H, Chen L, Xiao Y, Xing Y.
    Tumour Biol; 2016 Jun 15; 37(6):7599-613. PubMed ID: 26687646
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
    Xiao R, Wang H, Yang B.
    Bioengineered; 2021 Dec 15; 12(2):10596-10607. PubMed ID: 34895048
    [Abstract] [Full Text] [Related]

  • 15. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W, Han W, Fan T, Wang X, Cheng Z, Wan B, Chen J.
    Biomed Pharmacother; 2018 Nov 15; 107():1505-1513. PubMed ID: 30257368
    [Abstract] [Full Text] [Related]

  • 16. SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer.
    Li J, Wang X, Li Z, Li M, Zheng X, Zheng D, Wang Y, Xi M.
    Curr Cancer Drug Targets; 2024 Nov 15; 24(8):820-834. PubMed ID: 37539927
    [Abstract] [Full Text] [Related]

  • 17. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F, Zhou P, Wang Z, Zhang XL, Liao FX, Hu Y, Chang J.
    Arch Biochem Biophys; 2020 Jun 15; 686():108351. PubMed ID: 32240636
    [Abstract] [Full Text] [Related]

  • 18. Effects of hnRNP A2/B1 Knockdown on Inhibition of Glioblastoma Cell Invasion, Growth and Survival.
    Deng J, Chen S, Wang F, Zhao H, Xie Z, Xu Z, Zhang Q, Liang P, Zhai X, Cheng Y.
    Mol Neurobiol; 2016 Mar 15; 53(2):1132-1144. PubMed ID: 25586062
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K, Zhang T, Fan Y, Serick, Du G, Wu P, Geng D.
    Tumour Biol; 2016 Oct 15; 37(10):13469-13477. PubMed ID: 27465551
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J, Wert-Lamas L, Santisteban P.
    Oncogene; 2018 Jun 15; 37(25):3369-3383. PubMed ID: 29353884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.